The Second Multicenter Hemophilia Cohort Study
Study Details
Study Description
Brief Summary
The Second Multicenter Hemophilia Cohort Study (MHCS-II) will evaluate and prospectively follow approximately 4500 persons with hemophilia who were exposed to hepatitis C virus (HCV). The vast majority will have been infected with HCV, and approximately 1/3 will have been infected with human immunodeficiency virus (HIV). Primary objectives are to quantify the rates of liver decompensation, hepatocellular carcinoma, and non-Hodgkin lymphoma and to evaluate candidate clinical, genetic, virologic, serologic and immunologic markers that are likely to be on the causal pathway for these conditions. Candidate clinical and laboratory markers will be examined longitudinally to define changes over time and their relationships to one another. Collaborative studies will focus on genome scanning and evaluation of candidate genetic loci for susceptibility or resistance to HCV and HIV infections or to the diseases that result from these infections. Additional studies will identify response and complication rates of various anti-HCV and anti-HIV regimens in the setting of comprehensive clinical care of persons with hemophilia.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The Second Multicenter Hemophilia Cohort Study (MHCS-II) will evaluate and prospectively follow approximately 4500 persons with hemophilia who were exposed to hepatitis C virus (HCV). The vast majority will have been infected with HCV, and approximately 1/3 will have been infected with human immunodeficiency virus (HIV). Primary objectives are to quantify the rates of liver decompensation, hepatocellular carcinoma, and non-Hodgkin lymphoma and to evaluate candidate clinical, genetic, virologic, serologic and immunologic markers that are likely to be on the causal pathway for these conditions. Candidate clinical and laboratory markers will be examined longitudinally to define changes over time and their relationships to one another. Collaborative studies will focus on genome scanning and evaluation of candidate genetic loci for susceptibility or resistance to HCV and HIV infections or to the diseases that result from these infections. Additional studies will identify response and complication rates of various anti-HCV and anti-HIV regimens in the setting of comprehensive clinical care of persons with hemophilia.
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
- INCLUSION CRITERIA:
Must be registered patient with an inherited coagulation disorder at a participating MHCS-II center. Disorders include hemophilia A or B (congenital factor VIII or IX deficiency), deficiencies in other factors such as V or XI, and vonWillebrand's disease. (Unless noted otherwise, all of the disorders will collectively be referred to as hemophilia .) All such hemophilia and vonWillebrand s disease patients are to be recruited as study participants.
Since January 1, 1993, must have had at least one positive result on a licensed assay for HCV antibodies, HIV antibodies, or HIV RNA.
Must be at least 13 years of age at enrollment.
Must provide signed informed consent or, for minors, signed assent plus signed informed consent from the parent or guardian.
EXCLUSION CRITERIA:
Is not a patient with an inherited coagulation disorder.
Does not have a positive test for HCV antibodies, HIV antibodies, or HIV RNA on a licensed assay performed since January 1, 1993.
Is less than 13 years of age.
Lacks informed consent/assent.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Arizona | Tucson | Arizona | United States | 85724 |
2 | University of California, Davis | Davis | California | United States | 95616 |
3 | Children's Hospital of Orange County | Orange | California | United States | 92613 |
4 | University of California, San Francisco | San Francisco | California | United States | 94143 |
5 | University of Colorado | Denver | Colorado | United States | 80220-3706 |
6 | Christiana Hospital | Wilmington | Delaware | United States | |
7 | Georgetown University | Washington | District of Columbia | United States | 20007-2197 |
8 | Childrens National Medical Center | Washington | District of Columbia | United States | |
9 | Emory University | Atlanta | Georgia | United States | 30322-1102 |
10 | University of Illinois | Chicago | Illinois | United States | 60612 |
11 | Childrens Memorial Hospital, Chicago | Chicago | Illinois | United States | 60614-3394 |
12 | St. Vincent's Hospital | Indianapolis | Indiana | United States | |
13 | Tulane University | New Orleans | Louisiana | United States | 70112-2699 |
14 | Wayne State University Hutzel Hospital | Detroit | Michigan | United States | 48201 |
15 | University of Minnesota | Minneapolis | Minnesota | United States | 55415 |
16 | University of Mississippi | Jackson | Mississippi | United States | 39216 |
17 | St. Louis University | Saint Louis | Missouri | United States | 63104 |
18 | University of New Mexico | Albuquerque | New Mexico | United States | 87131 |
19 | University of Buffalo | Buffalo | New York | United States | |
20 | North Shore Long Island Jewish Health System | Lake Success | New York | United States | 11042 |
21 | Cornell University | New York | New York | United States | 10021-4872 |
22 | Mt. Sinai Medical Center | New York | New York | United States | 10029-0574 |
23 | University of North Carolina | Chapel Hill | North Carolina | United States | 27599-7030 |
24 | Wake Forest University | Winston-Salem | North Carolina | United States | 27103 |
25 | Childrens Hospital, Cinncinati | Cincinnati | Ohio | United States | 45229-3039 |
26 | University of Cincinnati | Cincinnati | Ohio | United States | 45267 |
27 | Ohio State University | Columbus | Ohio | United States | 43210-1240 |
28 | Wright State University | Dayton | Ohio | United States | 45435 |
29 | University of Oklahoma | Oklahoma City | Oklahoma | United States | |
30 | Milton Hershey Medical Center | Hershey | Pennsylvania | United States | 17033 |
31 | University of Pennsylvania | Philadelphia | Pennsylvania | United States | 19104-6056 |
32 | Thomas Jefferson University | Philadelphia | Pennsylvania | United States | 19107-6541 |
33 | Palmentto Health Alliance | Columbia | South Carolina | United States | 29202 |
34 | University of Tennessee | Memphis | Tennessee | United States | 38103 |
35 | Vanderbilt University | Nashville | Tennessee | United States | 37232 |
36 | University of Texas, Houston | Houston | Texas | United States | 77030 |
37 | University of Texas, San Antonio | San Antonio | Texas | United States | |
38 | University of Utah | Salt Lake City | Utah | United States | 84112 |
39 | Childrens Hospital of Wisconsin | Milwaukee | Wisconsin | United States | |
40 | Hospital Brigadeiro | Sao Paulo | Brazil | ||
41 | University of Sao Paulo | Sao Paulo | Brazil | ||
42 | South East Health Care Corporation | New Brunswick | Canada | ||
43 | Hospices Civils de Lyon | Lyons | France | ||
44 | University of Bonn | Bonn | Germany | ||
45 | Laikon General Hospital of Athens | Athens | Greece | ||
46 | University of Florence | Florence | Italy | ||
47 | University de Milano | Milan | Italy | ||
48 | Karolinska Institute St. Gorans Hospital | Stockholm | Sweden |
Sponsors and Collaborators
- National Cancer Institute (NCI)
- Multicenter Hemophilia Cohort Study
Investigators
- Principal Investigator: James J Goedert, M.D., National Cancer Institute (NCI)
Study Documents (Full-Text)
None provided.More Information
Publications
- Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr (1988). 1993 Jun;6(6):602-10.
- Kroner BL, Rosenberg PS, Aledort LM, Alvord WG, Goedert JJ. HIV-1 infection incidence among persons with hemophilia in the United States and western Europe, 1978-1990. Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr (1988). 1994 Mar;7(3):279-86.
- Mannucci PM, Tuddenbam EG. The hemophilias: progress and problems. Semin Hematol. 1999 Oct;36(4 Suppl 7):104-17. Review.
- 999901170
- 01-C-N170